Acute kidney injury, an often fatal condition without a specific treatment, affects up to 10 percent of all hospitalized adults
Continue reading »
Ivosidenib earns FDA approval against IDH1+ acute myeloid leukemia
Clinical trials at University of Colorado Cancer Center and elsewhere now result in the drug ivosidenib earning approval from the
Continue reading »FDA approves tibsovo for acute myeloid leukemia
(HealthDay)—Tibsovo (ivosidenib) tablets have been approved by the U.S. Food and Drug Administration to treat relapsed or refractory acute myeloid
Continue reading »BioSight Launches a Phase 2b Clinical Trial of BST-236 as a First-Line Treatment of Acute Myeloid Leukemia
AIRPORT CITY, Israel, July 11, 2018 /PRNewswire/ — BioSight Ltd., a pharmaceutical development company focused on the development of targeted
Continue reading »Decline in medicare patients who die in acute care hospitals
(HealthDay)—Medicare fee-for-service beneficiaries were less likely to die in acute care hospitals in 2015 than in 2000, according to a
Continue reading »VTE linked to acute decline in physical function in women
(HealthDay)—For women, venous thromboembolism (VTE) is associated with acute decline in physical function, according to a study published online June
Continue reading »Study suggests siblings of people with RA are at increased risk of acute coronary syndrome
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate an increased risk
Continue reading »Acute coronary syndrome patients with short sleep have double odds of hospital readmission
Pilot data from a recent study suggest that patients with short sleep have over two times the odds of readmission
Continue reading »Triggers of acute heart failure vary globally
Triggers of acute heart failure vary globally, according to late breaking results from the REPORT-HF registry presented today at Heart
Continue reading »New potential target identified to fight acute myeloid leukemia
AML is not a single disease. It is a group of leukemias that develop in the bone marrow from progenitors
Continue reading »